FDA.reportPublic FDA data

Application 021175

Type
NDA
Sponsor
US ARMY

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ATNAAATROPINE; PRALIDOXIME CHLORIDEINJECTABLE;INTRAMUSCULAR2.1MG/0.7ML;600MG/2MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
11704-777ATNAA atropine and pralidoxime chlorideatropine and pralidoxime chlorideMeridian Medical Technologies, Inc.NDACurrent
11704-777ATNAA atropine and pralidoxime chlorideatropine and pralidoxime chlorideMeridian Medical Technologies, Inc.NDACurrent
11704-777ATNAA atropine and pralidoxime chlorideatropine and pralidoxime chlorideMeridian Medical Technologies, Inc.NDACurrent
11704-777ATNAA atropine and pralidoxime chlorideatropine and pralidoxime chlorideMeridian Medical Technologies, Inc.NDACurrent
11704-777ATNAA atropine and pralidoxime chlorideatropine and pralidoxime chlorideMeridian Medical Technologies LLCNDACurrent
11704-777ATNAA atropine and pralidoxime chlorideatropine and pralidoxime chlorideMeridian Medical Technologies LLCNDACurrent
11704-777ATNAA atropine and pralidoxime chlorideatropine and pralidoxime chlorideMeridian Medical Technologies, LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
71189SUPPL2022-06-01
71165SUPPL2022-05-31
63316SUPPL2020-05-28
63291SUPPL2020-05-26
42001ORIG2004-05-27
26991ORIG2002-01-17
14571ORIG2002-01-17